One might think that we had enough crises already without creating a new one, but apparently that’s not the case. To much fanfare, the Biden Administration unveiled its long awaited “guidelines” for agency use of the march in rights provision of the Bayh-Dole Act. Ironically, it started this exercise just as it had joined every other administration in dismissing attempts to misuse the statute as a pretext for the government to micro-manage the price of a successfully commercialized government funded invention.
Recent Posts
- Senate IP Subcommittee Talks Legislative Fixes for China’s Threats to American Innovation Leadership
- Another Director Review Request Demonstrates Extent of PTAB Hubris
- The Existential Threat of AI Consciousness | IPWatchdog Unleashed
- Latest Trump Executive Order Redirects Drug Pricing Debate
- Lutnick Tells Inventors, ‘You Have a Friend’ at Commerce